MorphoSys Corporation - MOR Company Short-Term Debt

MorphoSys Corp (MOR) - corporate logo

German biotech firm MorphoSys AG (MOR) generates revenue through exclusive antibody rights for lymphoma therapy, which enables the company to maintain high drug pricing power. The price action (separate_debt_short) reflects the 0.00 metric. MorphoSys AG (MOR) is implementing robotics to accelerate drug discovery, freeing scientists from routine tasks. Meanwhile, the business relies on a stable legal status in the US and Europe, which eliminates sanction risks.

Company Short-Term Loans and Borrowings: morphosys.com (MOR) for 07/04/2022 - 08/10/2024

MorphoSys Corporation - analytical breakdowns and key metrics (MOR)

- price and consensus price forecast:
Stock Price MorphoSys|MOR - Average Forecast Price
- market capitalization data:
Market Value MorphoSys AG|MOR - Value Adjusted for Debt and Cash
- book capitalization data:
Accounting Value per Share MorphoSys|MOR - Accounting Value of Company|Market Capitalization to Book Value Ratio morphosys.com|MOR - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio MorphoSys AG|MOR - Long-Term Debt to Capital|Short-Term Debt to Equity MorphoSys AG|MOR - Aggregate Debt Obligations|Debts to Book Capitalization MorphoSys AG|MOR - Long-Term Debt|Company Short-Term Debt MorphoSys
Analysis of all company metrics:MorphoSys, MOR
Manufactured products of MorphoSys AG

Short-term debt measures the volume of obligations with a maturity of up to one year, reflecting the risk of an immediate loss of liquidity in the event of cash flow disruptions. For MorphoSys AG, this indicator represents the cost of operational maintenance for biochemical production and logistics, making historical short-term debt data a key tool for monitoring the company's financial stability under conditions of strict environmental compliance.

Competitor analysis for MorphoSys AG

ONC (BeiGene) - Company Short-Term Debts|HALO: Short-Term Debt|Company Short-Term Debt RevMed RVMD|Company Short-Term Loans and Borrowings Ascentage Pharma Corp|CGON - Company Current Liabilities|Company Short-Term Loans and Borrowings urogen.com|Company Short-Term Debts BCAX (Bicara Therapeutics)|Company Current Liabilities Personalis Inc PSNL|Company Current Liabilities ERAS (Erasca Corp)|Delcath Corp - Company Short-Term Debts|Company Short-Term Debt Y-mAbs Therapeutics (YMAB)|AURA - Company Short-Term Loans and Borrowings|Company Short-Term Debts CADL|ARAY (Accuray Inc) - Short-Term Debt|Company Short-Term Debt SLS|Company Current Liabilities ACTU|Citius Oncology, Inc. - Company Short-Term Debt|Short-Term Debt HURA (tuhurabio.com)|Company Short-Term Debt Protara Therapeutics, Inc.|Fate Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt Aadi Bio|TCRX - Current Liabilities|Company Short-Term Debts championsoncology.com CSBR|XBIT (XBiotech) - Company Short-Term Loans and Borrowings|Company Short-Term Debt CVM (CEL-SCI Corp.)|Short-Term Debt OSTX|RADX (Radiopharm Theranostics) - Company Short-Term Debt|Short-Term Debt Volume artivabio.com ARTV|ANL: Company Current Liabilities|verupharma.com - Short-Term Debt|Company Short-Term Debt TPST (Tempest Therapeutics, Inc.)|Xilio Therapeutics, Inc. (XLO) - Short-Term Debt Volume|Company Current Liabilities renovarobio.com RENB|Mural Oncology (MURA) - Company Short-Term Loans and Borrowings|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|Company Short-Term Debts OnKure|GDTC: Company Short-Term Debts|Short-Term Indebtedness CRIS (curis.com)|Apollomics - Company Short-Term Debt|Tharimmune Corporation - Company Current Liabilities|ADVB (Advanced Biomed Corp) - Company Short-Term Debt|GNPX: Short-Term Debt|Company Short-Term Debt calidibio.com CLDI|sunshinebiopharma.com (SBFM) - Company Short-Term Loans and Borrowings|Company Short-Term Debts XBIO|Company Current Liabilities Salarius Pharma|Company Short-Term Debts PPBT|Company Short-Term Debts AONC (aoncology.com)|BGNE - Company Short-Term Debt|Company Short-Term Indebtedness Checkpoint Therapeutics Inc. CKPT|ELEV: Company Short-Term Debts|ICAD - Company Current Liabilities|Company Short-Term Debts IKNA|NTBL (notablelabs.com) - Short-Term Debt|VIRX - Company Short-Term Debt|Company Short-Term Loans and Borrowings NAYA Biosciences Inc (NAYA)|Ascentage Pharma Group Ltd (AAPGV) - Company Current Liabilities